ESTA Establishment Labs
- 52.600
- +3.100+6.26%
Establishment Labs News
Establishment Labs Notes Presentation of 4-Year Results From Motiva U.S. IDE Study at The Aesthetic Meeting 2024
Establishment Labs Holdings Inc. (NASDAQ:ESTA), a global medical technology company dedicated to improving women's health and wellness, principally in breast aesthetics and reconstruction, noted the presentation today
Express News | Establishment Labs Announces Appointment of Jeff Ehrhardt as General Manager of North America
Establishment Labs to Announce First Quarter 2024 Financial Results on May 8
Establishment Labs Holdings Inc. (NASDAQ:ESTA), a global medical technology company dedicated to improving women's health and wellness, principally in breast aesthetics and reconstruction, plans to announce its
Establishment Labs Announces Participation in The Aesthetic Meeting 2024
Establishment Labs Holdings Inc. (NASDAQ:ESTA), a global medical technology company dedicated to improving women's health and wellness, principally in breast aesthetics and reconstruction, today announced its
Establishment Labs Is Maintained at Buy by Citigroup
Establishment Labs Is Maintained at Buy by Citigroup
Citigroup Maintains Buy on Establishment Labs Hldgs, Raises Price Target to $60
Citigroup analyst Joanne Wuensch maintains Establishment Labs Hldgs (NASDAQ:ESTA) with a Buy and raises the price target from $49 to $60.
Analysts Offer Insights on Healthcare Companies: Establishment Labs Holdings (ESTA) and Gritstone Oncology (GRTS)
Establishment Labs Says US FDA Schedules Preapproval Inspection of Motiva Implants Facility
Establishment Labs (ESTA) said Tuesday that the US Food and Drug Administration scheduled a PMA preapproval inspection of the company's manufacturing facility for Motiva Implants. The inspection is se
Establishment Labs Is Maintained at Buy by Mizuho
Establishment Labs Is Maintained at Buy by Mizuho
Express News | Mizuho Maintains Buy on Establishment Labs Hldgs, Raises Price Target to $65
10 Health Care Stocks Whale Activity In Today's Session
Traders often look for circumstances when the market estimation of an option diverges away from its normal worth.
Establishment Labs Poised for Robust Growth With Motiva Expansion and Upcoming Market Entries
Establishment Labs Is Maintained at Outperform by TD Cowen
Establishment Labs Is Maintained at Outperform by TD Cowen
Express News | TD Cowen Maintains Outperform on Establishment Labs Hldgs, Raises Price Target to $60
Buy Rating Affirmed for Establishment Labs on Positive FDA Approval Progress and Strong GMP Preparedness
New Regulation Risk for Establishment Labs Holdings – What's the Latest?
Establishment Labs Holdings Up Over 23%, on Pace for Largest Percent Increase Since October 2020 -- Data Talk
Establishment Labs Holdings, Inc. ( ESTA ) is currently at $47.34, up $8.89 or 23.1% --Would be highest close since Sept. 29, 2023, when it closed at $49.07 --On pace for largest percent increase si
Establishment Labs Price Target Raised to $53.00/Share From $46.00 by JP Morgan
Establishment Labs Price Target Raised to $53.00/Share From $46.00 by JP Morgan
Establishment Labs Is Maintained at Overweight by JP Morgan
Establishment Labs Is Maintained at Overweight by JP Morgan
Hormel Foods Reports Upbeat Earnings, Joins Pure Storage, Okta, Papa John's International And Other Big Stocks Moving Higher On Thursday
U.S. stocks were higher, with the Nasdaq Composite gaining around 50 points on Thursday. Shares of Hormel Foods Corporation (NYSE:HRL) rose sharply during Thursday's session after the company reporte
Analysis
Price Target
No Data
